黑石集团旗下生命科学部门与强生公司宣布达成合作协议,双方将共同出资支持Bleximenib药物的部分临床试验项目。此次合作旨在加速该创新疗法的研发进程,为患者提供新的治疗选择。
黑石集团旗下生命科学部门与强生公司宣布达成合作协议,双方将共同出资支持Bleximenib药物的部分临床试验项目。此次合作旨在加速该创新疗法的研发进程,为患者提供新的治疗选择。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.